[
  {
    "ts": "2026-02-07T15:08:49+00:00",
    "headline": "Jim Cramer Discusses Bristol Myers’s (BMY) Cobenfy Drug",
    "summary": "We recently published 12 Stocks Jim Cramer Talked About. Bristol Myers Squibb Company (NYSE:BMY) is one of the stocks that Jim Cramer talked about. Bristol Myers Squibb Company (NYSE:BMY) is one of the largest pharmaceutical companies in the world. Its shares are up by 7.5% over the past year and by 15.4% year-to-date. Piper Sandler […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-discusses-bristol-myers-150849420.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9c86b592-8f73-3d6c-b46f-2e0b8dc7ca08",
      "content": {
        "id": "9c86b592-8f73-3d6c-b46f-2e0b8dc7ca08",
        "contentType": "STORY",
        "title": "Jim Cramer Discusses Bristol Myers’s (BMY) Cobenfy Drug",
        "description": "",
        "summary": "We recently published 12 Stocks Jim Cramer Talked About. Bristol Myers Squibb Company (NYSE:BMY) is one of the stocks that Jim Cramer talked about. Bristol Myers Squibb Company (NYSE:BMY) is one of the largest pharmaceutical companies in the world. Its shares are up by 7.5% over the past year and by 15.4% year-to-date. Piper Sandler […]",
        "pubDate": "2026-02-07T15:08:49Z",
        "displayTime": "2026-02-07T15:08:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "Jim Cramer Discusses Bristol Myers's (BMY) Cobenfy Drug",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L.y5eHntIJd0XzA2FsxbTA--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6ji6jibByYrwJ8.gSBa.ig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-bristol-myers-150849420.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-bristol-myers-150849420.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-07T15:45:39+00:00",
    "headline": "Bristol Myers price target raised to $40 from $37 at Morgan Stanley",
    "summary": "Morgan Stanley analyst Terence Flynn raised the firm’s price target on Bristol Myers (BMY) to $40 from $37 and keeps an Underweight rating on the shares. 2026 revenue and EPS guidance came in above consensus, but was driven by a higher than expected Eliquis guide, the analyst tells investors in a research note.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximi",
    "url": "https://finance.yahoo.com/news/bristol-myers-price-target-raised-154539884.html",
    "source": "TipRanks",
    "provider": "yfinance",
    "raw": {
      "id": "5034cc74-a9a4-3d3e-8146-ee13511b2ab5",
      "content": {
        "id": "5034cc74-a9a4-3d3e-8146-ee13511b2ab5",
        "contentType": "STORY",
        "title": "Bristol Myers price target raised to $40 from $37 at Morgan Stanley",
        "description": "",
        "summary": "Morgan Stanley analyst Terence Flynn raised the firm’s price target on Bristol Myers (BMY) to $40 from $37 and keeps an Underweight rating on the shares. 2026 revenue and EPS guidance came in above consensus, but was driven by a higher than expected Eliquis guide, the analyst tells investors in a research note.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximi",
        "pubDate": "2026-02-07T15:45:39Z",
        "displayTime": "2026-02-07T15:45:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/tipranks_452/b283ad7faa9680c3e9623f6536014bcd",
          "originalWidth": 192,
          "originalHeight": 192,
          "caption": "https://www.tipranks.com/news/the-fly/bristol-myers-price-target-raised-to-40-from-37-at-morgan-stanley-thefly",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L_QzXFOw6tvO2n9ieo4KMw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/b283ad7faa9680c3e9623f6536014bcd.cf.webp",
              "width": 192,
              "height": 192,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XA3lrHwh5F9JVuBl4VtAAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/b283ad7faa9680c3e9623f6536014bcd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TipRanks",
          "url": "https://www.tipranks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-price-target-raised-154539884.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-price-target-raised-154539884.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]